CBX4
Basic information
Region (hg38): 17:79833156-79839440
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CBX4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 41 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 41 | 0 | 2 |
Variants in CBX4
This is a list of pathogenic ClinVar variants found in the CBX4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-79833966-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
17-79833994-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
17-79834033-A-G | not specified | Uncertain significance (May 04, 2022) | ||
17-79834049-G-T | not specified | Uncertain significance (Dec 21, 2023) | ||
17-79834077-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
17-79834118-T-TGCCGCC | Benign (May 21, 2018) | |||
17-79834189-C-T | not specified | Uncertain significance (Jun 28, 2024) | ||
17-79834194-T-G | not specified | Uncertain significance (Dec 25, 2024) | ||
17-79834255-T-A | not specified | Uncertain significance (May 08, 2023) | ||
17-79834258-C-T | not specified | Uncertain significance (Feb 13, 2024) | ||
17-79834263-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
17-79834285-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
17-79834299-G-A | not specified | Uncertain significance (Aug 12, 2022) | ||
17-79834303-G-A | not specified | Uncertain significance (Mar 01, 2024) | ||
17-79834332-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
17-79834396-C-G | not specified | Uncertain significance (Dec 19, 2023) | ||
17-79834417-C-T | not specified | Uncertain significance (Nov 20, 2024) | ||
17-79834442-G-T | not specified | Uncertain significance (May 17, 2023) | ||
17-79834451-G-C | not specified | Uncertain significance (Dec 01, 2022) | ||
17-79834459-G-C | not specified | Uncertain significance (Mar 27, 2023) | ||
17-79834477-G-T | not specified | Uncertain significance (Sep 29, 2023) | ||
17-79834501-A-G | not specified | Uncertain significance (Dec 16, 2023) | ||
17-79834539-A-T | not specified | Uncertain significance (May 12, 2024) | ||
17-79834582-C-A | not specified | Uncertain significance (Mar 18, 2024) | ||
17-79834593-G-C | not specified | Uncertain significance (Feb 23, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CBX4 | protein_coding | protein_coding | ENST00000269397 | 5 | 6274 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.982 | 0.0180 | 125704 | 0 | 2 | 125706 | 0.00000796 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.22 | 261 | 383 | 0.681 | 0.0000261 | 3626 |
Missense in Polyphen | 68 | 140.89 | 0.48263 | 1431 | ||
Synonymous | 0.228 | 176 | 180 | 0.978 | 0.0000141 | 1129 |
Loss of Function | 3.55 | 1 | 16.6 | 0.0601 | 7.13e-7 | 222 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000893 | 0.00000879 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 SUMO-protein ligase which facilitates SUMO1 conjugation by UBE2I (PubMed:12679040). Involved in the sumoylation of HNRNPK, a p53/TP53 transcriptional coactivator, hence indirectly regulates p53/TP53 transcriptional activation resulting in p21/CDKN1A expression. Monosumoylates ZNF131 (PubMed:22825850). {ECO:0000269|PubMed:12679040, ECO:0000269|PubMed:22825850}.;
- Pathway
- Signal Transduction;Gene expression (Transcription);RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known;the prc2 complex sets long-term gene silencing through modification of histone tails;Generic Transcription Pathway;Oxidative Stress Induced Senescence;SUMOylation of DNA damage response and repair proteins;Cellular Senescence;SUMOylation of chromatin organization proteins;Cellular responses to stress;SUMOylation of RNA binding proteins;Post-translational protein modification;SUMO E3 ligases SUMOylate target proteins;Metabolism of proteins;RNA Polymerase II Transcription;SUMOylation;Cellular responses to external stimuli;Regulation of PTEN gene transcription;PTEN Regulation;PIP3 activates AKT signaling;C-MYB transcription factor network;Intracellular signaling by second messengers;Transcriptional regulation by RUNX1;Regulation of retinoblastoma protein
(Consensus)
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- loftool
- 0.0942
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.73
Haploinsufficiency Scores
- pHI
- 0.879
- hipred
- Y
- hipred_score
- 0.630
- ghis
- 0.411
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.369
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cbx4
- Phenotype
- growth/size/body region phenotype; endocrine/exocrine gland phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;chromatin organization;protein sumoylation;negative regulation of apoptotic process;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus;nucleoplasm;nuclear body;nuclear speck;PcG protein complex;PRC1 complex
- Molecular function
- chromatin binding;transcription corepressor activity;single-stranded RNA binding;protein binding;SUMO transferase activity;enzyme binding;SUMO binding;methylated histone binding;transcription regulatory region DNA binding;phosphoprotein binding